Sign inGet started

Sacks Natalie

Insider CIK 1683811 · ZYME Director · ADRO Chief Medical Officer · CRBU Director · HARP Chief Medical Officer · ZYME Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CRBU Caribou Biosciences, Inc. A Award deriv2026-02-202026-02-2045,000— $045,000SEC↗
CRBU Caribou Biosciences, Inc. A Award deriv2025-02-202025-02-2140,500— $040,500SEC↗
CRBU Caribou Biosciences, Inc. A Award deriv2024-02-202024-02-2239,500— $039,500SEC↗
CRBU Caribou Biosciences, Inc. A Award deriv2023-02-212023-02-2321,500— $021,500SEC↗
ZYME Zymeworks Inc. A Award deriv2022-12-212022-12-2325,000— $025,000SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2022-01-282022-02-01155,000— $0155,000SEC↗
CRBU Caribou Biosciences, Inc. A Award deriv2021-12-202021-12-2127,500— $027,500SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2021-11-112021-11-15155,000— $0155,000SEC↗
ZYME Zymeworks Inc. A Award deriv2021-05-062021-05-079,000— $09,000SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2021-01-282021-01-2980,000— $080,000SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2020-05-182020-05-201,522— $045,625SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2020-05-182020-05-201,522$14.77 $22.5K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2020-05-182020-05-201,522$2.12 $3.2K47,276SEC↗
ZYME Zymeworks Inc. A Award deriv2020-05-082020-05-129,000— $09,000SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2020-05-012020-05-055,826— $0168,926SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2020-05-012020-05-055,826$12.07 $70.3K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2020-05-012020-05-055,826$2.12 $12.4K51,580SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2020-04-172020-04-171,021— $047,147SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2020-04-172020-04-171,021$12.08 $12.3K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2020-04-172020-04-171,021$2.12 $2.2K46,775SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2020-04-162020-04-17500— $048,168SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2020-04-162020-04-17500$12.00 $6.0K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2020-04-162020-04-17500$2.12 $1.1K46,254SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2020-04-132020-04-154,556— $0174,752SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2020-04-132020-04-154,556$12.06 $54.9K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2020-04-132020-04-154,556$2.12 $9.7K50,310SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2020-04-072020-04-08570— $0179,308SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2020-04-072020-04-08570$12.00 $6.8K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2020-04-072020-04-08570$2.12 $1.2K46,324SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2020-04-062020-04-08700— $0179,878SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2020-04-062020-04-08700$12.00 $8.4K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2020-04-062020-04-08700$2.12 $1.5K46,454SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2020-03-172020-03-181,520— $048,668SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2020-03-172020-03-181,520$2.12 $3.2K47,274SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2020-03-172020-03-181,520$12.00 $18.2K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2020-03-162020-03-181— $050,188SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2020-03-162020-03-181$2.12 $245,755SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2020-03-162020-03-181$12.00 $1245,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2020-03-022020-03-035,826— $0180,578SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2020-03-022020-03-035,826$14.68 $85.5K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2020-03-022020-03-035,826$2.12 $12.4K51,580SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2020-02-182020-02-201,521— $050,189SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2020-02-182020-02-201,521$15.00 $22.8K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2020-02-182020-02-201,521$2.12 $3.2K47,275SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2020-02-032020-02-045,826— $0186,404SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2020-02-032020-02-045,826$13.90 $81.0K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2020-02-032020-02-045,826$2.12 $12.4K51,580SEC↗
HARP Harpoon Therapeutics, Inc. A Award deriv2020-01-312020-02-0475,440— $075,440SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2020-01-162020-01-211,521— $051,710SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2020-01-162020-01-211,521$2.12 $3.2K47,275SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2020-01-162020-01-211,521$14.94 $22.7K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2020-01-022020-01-065,826— $0192,230SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2020-01-022020-01-065,826$14.18 $82.6K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2020-01-022020-01-065,826$2.12 $12.4K51,580SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2019-12-162019-12-181,521— $053,231SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2019-12-162019-12-181,521$17.02 $25.9K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2019-12-162019-12-181,521$2.12 $3.2K47,275SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2019-12-022019-12-045,826— $0198,056SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2019-12-022019-12-045,826$17.98 $104.8K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2019-12-022019-12-045,826$2.12 $12.4K51,580SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2019-11-182019-11-1918,252— $054,752SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2019-11-182019-11-1918,252$2.12 $38.7K64,006SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2019-11-182019-11-191,000$14.00 $14.0K45,754SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2019-11-182019-11-1917,252$13.33 $230.0K46,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2019-11-012019-11-055,826— $0203,882SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2019-11-012019-11-055,826$13.17 $76.7K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2019-11-012019-11-055,826$2.12 $12.4K51,580SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2019-10-152019-10-1611,698— $0209,708SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2019-10-152019-10-1611,698$2.12 $24.8K57,452SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2019-10-152019-10-1611,698$13.21 $154.5K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise deriv2019-10-142019-10-1612,452— $0221,406SEC↗
HARP Harpoon Therapeutics, Inc. S Sale2019-10-142019-10-1612,452$13.27 $165.2K45,754SEC↗
HARP Harpoon Therapeutics, Inc. M Exercise2019-10-142019-10-1612,452$2.12 $26.4K58,206SEC↗
ZYME Zymeworks Inc. A Award deriv2019-05-062019-05-0810,000— $010,000SEC↗
ADRO ADURO BIOTECH, INC. S Sale2018-09-132018-09-143,028$6.50 $19.7K173,720SEC↗
ADRO ADURO BIOTECH, INC. A Award2018-09-122018-09-1487,200— $0176,748SEC↗
ADRO ADURO BIOTECH, INC. S Sale2018-09-042018-09-064,504$7.13 $32.1K89,548SEC↗
ADRO ADURO BIOTECH, INC. A Award deriv2018-02-082018-02-12174,400— $0174,400SEC↗
ADRO ADURO BIOTECH, INC. A Award2017-12-112017-12-1316,312— $094,052SEC↗
ADRO ADURO BIOTECH, INC. A Award2017-09-122017-09-1432,625— $077,740SEC↗
ADRO ADURO BIOTECH, INC. S Sale2017-09-012017-09-064,885$11.71 $57.2K45,115SEC↗
ADRO ADURO BIOTECH, INC. A Award deriv2017-06-122017-06-1432,625— $032,625SEC↗
ADRO ADURO BIOTECH, INC. A Award deriv2016-09-122016-09-14250,000— $0250,000SEC↗
ADRO ADURO BIOTECH, INC. A Award2016-09-122016-09-1450,000— $050,000SEC↗